Article ; Online: Natural Anti-Cancer Agents: Implications in Gemcitabine-Resistant Pancreatic Cancer Treatment.
Mini reviews in medicinal chemistry
2017 Volume 17, Issue 11, Page(s) 920–927
Abstract: Background & objective: Pancreatic cancer is one of the most lethal malignancies accounting for the fourth leading cause of cancer-related deaths in the United States. Among several explored anticancer agents, Gemcitabine, a nucleoside analogue remained ...
Abstract | Background & objective: Pancreatic cancer is one of the most lethal malignancies accounting for the fourth leading cause of cancer-related deaths in the United States. Among several explored anticancer agents, Gemcitabine, a nucleoside analogue remained a front line chemotherapeutic agent for the treatment of pancreatic cancer. However, gemcitabine exerts a low response rate with limited progression free survival in patients due to cellular resistance of pancreatic tumors to this therapy. Several chemotherapeutic agents have been explored in combination with gemcitabine against pancreatic cancer with overall mixed responses and survival rates. Naturally occurring dietary agents possess promising anticancer properties and have been shown to target various oncogenic signaling pathways in in-vitro and in-vivo pancreatic cancer models. Results: Multiple studies using natural compounds have shown increased therapeutic efficacy of gemcitabine in pancreatic cancer models. Conclusion: This review is focused on recent updates on cellular, preclinical and clinical studies utilizing natural anticancer agents with gemcitabine against pancreatic cancer. |
---|---|
MeSH term(s) | Antineoplastic Agents/therapeutic use ; Biological Products/therapeutic use ; Combined Modality Therapy ; Curcumin/therapeutic use ; Deoxycytidine/analogs & derivatives ; Deoxycytidine/therapeutic use ; Drug Resistance, Neoplasm ; Humans ; Pancreatic Neoplasms/diet therapy ; Pancreatic Neoplasms/drug therapy |
Chemical Substances | Antineoplastic Agents ; Biological Products ; Deoxycytidine (0W860991D6) ; gemcitabine (B76N6SBZ8R) ; Curcumin (IT942ZTH98) |
Language | English |
Publishing date | 2017 |
Publishing country | Netherlands |
Document type | Journal Article ; Review |
ZDB-ID | 2104081-3 |
ISSN | 1875-5607 ; 1389-5575 |
ISSN (online) | 1875-5607 |
ISSN | 1389-5575 |
DOI | 10.2174/1389557517666170315124438 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 5891: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.